Literature DB >> 24343736

Clinical value of procalcitonin for patients with suspected bloodstream infection.

Takuya Hattori1, Hideki Nishiyama, Hideki Kato, Shinobu Ikegami, Madoka Nagayama, Saori Asami, Miyuki Usami, Mayuko Suzuki, Itsuka Murakami, Makoto Minoshima, Hiroe Yamagishi, Norihiro Yuasa.   

Abstract

OBJECTIVES: Procalcitonin (PCT) might be a useful marker to exclude bacteremia or to predict the severity of bacteremia and its outcome. However, most previous studies of PCT were limited to particular patient populations. In addition, reports about PCT levels in patients with renal dysfunction have been conflicting. We investigated the predictive value of PCT in an unselected population with suspected bloodstream infections and also assessed the relationship between PCT and renal function.
METHODS: We retrospectively analyzed medical records of 1,331 patients (age ≥1 8 years) with suspected bloodstream infections who had concurrent biochemical data and blood culture results.
RESULTS: The PCT level was significantly elevated in patients with positive blood cultures, and it showed a significant relation with survival in patients with bacteremia. The optimal cutoff value of PCT for predicting a positive blood culture showed an increase as the estimated glomerular filtration rate declined.
CONCLUSION: PCT can be a useful marker to exclude bacteremia and also to predict severe bacteremia, but renal function should be taken into account.

Entities:  

Keywords:  Blood culture; Bloodstream infection; C-reactive protein; Procalcitonin; Renal function

Mesh:

Substances:

Year:  2014        PMID: 24343736     DOI: 10.1309/AJCP4GV7ZFDTANGC

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  19 in total

1.  Comparison of serum procalcitonin in respiratory infections and bloodstream infections.

Authors:  Yanhui Zhu; Yulin Yuan; Huayi Huang
Journal:  Int J Clin Exp Med       Date:  2015-11-15

2.  The Diagnostic Accuracy of Serum Procalcitonin for Bacteremia in Critically Ill Children.

Authors:  Marianne E Nellis; Steven Pon; Ashley E Giambrone; Nana E Coleman; Jonathan Reiss; Elizabeth Mauer; Bruce M Greenwald
Journal:  Infect Dis Clin Pract (Baltim Md)       Date:  2016-11

Review 3.  Procalcitonin: Where Are We Now?

Authors:  Bachar Hamade; David T Huang
Journal:  Crit Care Clin       Date:  2019-10-21       Impact factor: 3.598

Review 4.  Role of procalcitonin use in the management of sepsis.

Authors:  Claudia Gregoriano; Eva Heilmann; Alexandra Molitor; Philipp Schuetz
Journal:  J Thorac Dis       Date:  2020-02       Impact factor: 2.895

5.  Diagnostic value of procalcitonin for acute complicated appendicitis.

Authors:  Hiromasa Yamashita; Norihiro Yuasa; Eiji Takeuchi; Yasutomo Goto; Hideo Miyake; Kanji Miyata; Hideki Kato; Masafumi Ito
Journal:  Nagoya J Med Sci       Date:  2016-02       Impact factor: 1.131

Review 6.  Utility of blood procalcitonin concentration in the management of cancer patients with infections.

Authors:  Bonita Durnaś; Marzena Wątek; Tomasz Wollny; Katarzyna Niemirowicz; Michał Marzec; Robert Bucki; Stanisław Góźdź
Journal:  Onco Targets Ther       Date:  2016-01-22       Impact factor: 4.147

7.  Serum procalcitonin levels distinguish Gram-negative bacterial sepsis from Gram-positive bacterial and fungal sepsis.

Authors:  Shuhua Li; Hengmo Rong; Qinliang Guo; Yifei Chen; Guqing Zhang; Jiong Yang
Journal:  J Res Med Sci       Date:  2016-06-14       Impact factor: 1.852

8.  Diagnostic Accuracy of Procalcitonin for Differentiating Bacteraemic Gram-Negative Sepsis from Gram-Positive Sepsis.

Authors:  Beliz Bilgili; Murat Haliloğlu; Melek Süzer Aslan; İsmet Sayan; Umut Sabri Kasapoğlu; İsmail Cinel
Journal:  Turk J Anaesthesiol Reanim       Date:  2018-02-01

9.  Diagnostic Accuracy of Procalcitonin for Predicting Blood Culture Results in Patients With Suspected Bloodstream Infection: An Observational Study of 35,343 Consecutive Patients (A STROBE-Compliant Article).

Authors:  Abderrahim Oussalah; Janina Ferrand; Pierre Filhine-Tresarrieu; Nejla Aissa; Isabelle Aimone-Gastin; Fares Namour; Matthieu Garcia; Alain Lozniewski; Jean-Louis Guéant
Journal:  Medicine (Baltimore)       Date:  2015-11       Impact factor: 1.889

10.  Can We Reduce Negative Blood Cultures With Clinical Scores and Blood Markers? Results From an Observational Cohort Study.

Authors:  Svenja Laukemann; Nina Kasper; Prasad Kulkarni; Deborah Steiner; Anna Christina Rast; Alexander Kutz; Susan Felder; Sebastian Haubitz; Lukas Faessler; Andreas Huber; Christoph A Fux; Beat Mueller; Philipp Schuetz
Journal:  Medicine (Baltimore)       Date:  2015-12       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.